1-16 of 16
Francisco-Javier Penalver
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Importance of Early Rescue and Relative Dose-Intensity in the Salvage Therapy with Tafasitamab-Lenalidomide in Diffuse Large B-Cell Lymphoma: Real-Life Study in Spain (GELTAMO)

Free
Antonio Gutiérrez, Izaskun Zeberio, Pilar Martinez-Barranco, Francisco Javier Peñalver, Sandra Pérez, Daniel Morillo, Xabier Mart N Martitegui, Concepción Nicolås, Ainara Ferrero, Ana Jiménez Ubieto, Mariana Bastos-Oreiro, Julio Dåvila-Valls, Maria Victoria Calle Gordo, María Pérez Sala, Guillermo Rodríguez Garcia, Aranzazu Alonso Alonso, Ana Garcia Noblejas, Diana Sanchez Arguello, Teresa Knight Asorey, Maria Angeles Fernandez Fernandez, Javier López Marin, Jaime Perez de Oteyza, Sonia Gonzålez De Villambrosia, Elena Perez Ceballos, Alejandro Marin, Belén Navarro, Ruben Fernandez Alvarez, Pilar Gómez, Jose Antonio Hueso, Maria Jesus Penarrubia Ponce, Pilar Bravo, Daniel García Belmonte, Haridian De La Nuez Melian, Sara Nistal, Pau Abrisqueta Costa, Fernanda Ibañez, Luis Palomera, Eva Donato, Andrea Provencio Rincon, Maria Stefania Infante, Eva Gonzalez Barca
Journal: Blood
Blood (2024) 144 (Supplement 1): 2356.
https://doi.org/10.1182/blood-2024-210868
Published: 2024
Journal Articles

R-COMP Vs. R-CHOP As First-Line Treatment for De Novo Diffuse Large B-Cell Lymphoma in Patients Older Than 60 Years: Preliminary Results from a Prospective Randomized Phase 2 Study from the Spanish Group Geltamo

Free
Juan-Manuel Sancho, Francisco Gual, Rubén Fernåndez-Alvarez, Esther Gonzålez-García, MD, Carlos Grande, MD PhD, Carmen Jiménez-López, Norma C Gutierrez, MD PhD, María-José Peñarrubia, Ana Batlle, Eva Gonzålez-Barca, MD PhD, Jose-Maria Guinea-de-Castro, Eva Gimeno, MD PhD, Francisco-Javier Peñalver, MD, Miguel A Fuertes, Jorge Gayoso, MD, José-Ángel Hernåndez-Rivas, José-María Moraleda, MD PhD, Lluis Virgili, Alejandro Martín, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5387.
https://doi.org/10.1182/blood.V128.22.5387.5387
Published: 2016
Journal Articles

Response-Adapted Treatment with Rituximab/Bendamustine/Mitoxantrone/Dexamethasone and Maintenance Therapy with Rituximab in Patients with Follicular Lymphoma in Relapse or Refractory to First-Line Treatment with Immunochemotherapy. RBMDGELTAMO08 Trial

Free
Francisco Javier Peñalver Pårraga, José Antonio Mårquez Navarro, Soledad Durån Nieto, Pilar Giraldo Castellano, Carlos Montalbån Sanz, María José Ramírez Sånchez, Juan-Manuel Sancho Cia, María José Terol Castera, Francisco Javier Capote Huelva, Antonio Gutiérrez García, Blanca Sånchez Gonzålez, Antonio Salar Silvestre, Miguel Canales Albendea, MD PhD, María Dolores Caballero Barrigón
Journal: Blood
Blood (2016) 128 (22): 1788.
https://doi.org/10.1182/blood.V128.22.1788.1788
Published: 2016
Journal Articles

Phase 2 Randomized Trial Comparing Standard RCHOP Versus Brcap (bortezomib, rituximab, cyclophosphamide, adriamycin and prednisone) As First Line Treatment in Young Patients with High-Risk Diffuse Large B-Cell Lymphoma (DLBCL). a Study from Spanish Group Geltamo

Free
Eva Gonzålez-Barca, MD PhD, Estrella Carrillo-Cruz, MD, Carlos Grande, MD PhD, Alejandro Martín, MD PhD, Mónica Coronado, MD, Santiago Montes-Moreno, MD, Santiago Mercadal, MD, Josep Maria Roncero, MD, Jaime Pérez de Oteyza, MD, Concepción Nicolås, MD, María José Rodríguez-Salazar, MD, Juan-Manuel Sancho, Luis Palomera, MD PhD, Javier López-Jiménez, MD, Carmen Albo, MD, Francisco-Javier Peñalver, MD, José Ángel Hernåndez, MD, Armando López-Guillermo, MD PhD, María José Ramírez, MD, Isidro Jarque, MD, Joan Bargay, MD, Miguel Canales, MD PhD, Eulogio Conde, MD PhD, Dolores Caballero, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4201.
https://doi.org/10.1182/blood.V128.22.4201.4201
Published: 2016
Journal Articles

Usefulness of Serum-Free-Light-Chains-Ratio (SFLCR) and Serum Heavy-Light-Chains-Ratio (SHLCR) in Multiple Myeloma in the Context of Three GEM/Pethema Clinical Trials

Free
Lucia Lopez-Anglada, MDPhD, Cecilia Cueto-Felgueroso, Maria-Victoria Mateos, Laura Rosiñol, MDPhD, Albert Oriol, MDPhD, Ana Isabel Teruel, MD, Ana Lopez de la Guia, MD, Luis Palomera, MDPhD, Felipe de Arriba, MDPhD, Jose Mariano Hernandez, MD, Miquel Granell, MD, Francisco Javier Peñalver, MD, Ramon Garcia-Sanz, MDPhD, Juan Besalduch, MDPhD, Yolanda Gonzalez, MD, Rafael Martinez, MDPhD, Miguel Teodoro Hernandez, MDPhD, Norma C Gutierrez, Paloma Puerta, MD, Joan Blade, MDPhD, JesĂșs San Miguel, MDPhD, Juan JosĂ© Lahuerta, MDPhD, Joaquin Martinez Lopez, MDPhD
Journal: Blood
Blood (2015) 126 (23): 2962.
https://doi.org/10.1182/blood.V126.23.2962.2962
Published: 2015
Journal Articles

Phase 2 Randomized Trial Comparing 6 Cycles of Standard RCHOP Chemotherapy Vs 6 Cycles of Brcap (bortezomib, rituximab, cyclophosphamide, adriamicine and prednisone) As First Line Treatment in Young Patients with Poor Prognosis Diffuse Large B-Cell Lymphoma (DLBCL): Interim Analysis

Free
Eva GonzĂĄlez-Barca, MD PhD, Estrella Carrillo, Carlos Grande, MD, Alejandro MartĂ­n, MĂłnica Coronado, Santiago Montes-Moreno, Jaime Perez de Oteyza, ConcepciĂłn Nicolas, Juan-Manuel Sancho, Luis Palomera, MDPhD, Javier Lopez, Sr., MD PhD, Armando Lopez-Guillermo, Francisco Javier Peñalver, JosĂ© Ángel HernĂĄndez, MD, Maria Jose Ramirez, Isidro Jarque, Joan Bargay, MD, MÂȘ JosĂ© RodrĂ­guez, Miguel Canales, Carmen Albo, Maite Encuentra, Dolores Caballero
Journal: Blood
Blood (2015) 126 (23): 1514.
https://doi.org/10.1182/blood.V126.23.1514.1514
Published: 2015
Journal Articles

Flow Cytometric Detection of Liposomes in the CSF of Patients with NHL/ALL, Treated with Intrathecal Liposomal Cytarabine: Synonymous of Toxicity?

Free
Francisco Javier Peñalver, Martínez-Barranco Pilar, Lucía Villalón, MD, Manuel Barón, L Martín, Pilar Ricard, Karmele Arribalzaga, María José Garcia Bueno, Alberto Orfao, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5444.
https://doi.org/10.1182/blood.V124.21.5444.5444
Published: 2014
Journal Articles

GEM2005 trial update comparing VMP/VTP as induction in elderly multiple myeloma patients: do we still need alkylators?

Free
Clinical Trials & Observations
MarĂ­a-Victoria Mateos, Albert Oriol, JoaquĂ­n MartĂ­nez-LĂłpez, Ana-Isabel Teruel, Ana LĂłpez de la GuĂ­a, Javier LĂłpez, Enrique Bengoechea, Montserrat PĂ©rez, Rafael MartĂ­nez, Luis Palomera, Felipe de Arriba, Yolanda GonzĂĄlez, JosĂ© Mariano HernĂĄndez, Miquel Granell, JosĂ©-Luis Bello, Joan Bargay, Francisco-Javier Peñalver, MarĂ­a-Luisa MartĂ­n-Mateos, Bruno Paiva, MarĂ­a-Angeles MontalbĂĄn, Joan BladĂ©, Juan-Jose Lahuerta, JesĂșs F. San-Miguel
Journal: Blood
Blood (2014) 124 (12): 1887–1893.
https://doi.org/10.1182/blood-2014-05-573733
Published: 2014
Journal Articles

Contribution of cerebrospinal fluid sCD19 levels to the detection of CNS lymphoma and its impact on disease outcome

Free
Brief Report
Carmen Muñiz, Lourdes Martín-Martín, Antonio López, Blanca Sånchez-Gonzålez, Antonio Salar, Julia Almeida, Juan-Manuel Sancho, José María Ribera, Cecilia Heras, Francisco Javier Peñalver, Marta Gómez, Eva Gonzålez-Barca, Natalia Alonso, Belén Navarro, Teresa Olave, Francisco Sala, Eulogio Conde, José Antonio Mårquez, Elena Cabezudo, Antonia Cladera, María García-Malo, María Dolores Caballero, Alberto Orfao
Journal: Blood
Blood (2014) 123 (12): 1864–1869.
https://doi.org/10.1182/blood-2013-11-537993
Published: 2014
Includes: Supplemental data
Journal Articles

Phase III Trial Of Bortezomib, Melphalan, and Prednisone (VMP) Versus Bortezomib, Thalidomide, and Prednisone (VTP) In Elderly Multiple Myeloma (MM) Patients: Update Follow-Up, Patterns Management Of First Relapse/Progression

Free
Aurelio Lopez, MD, Marta Valero, Ph, Jose Ignacio Lorenzo, MD, PhD, Maria-Victoria Mateos, MD, PhD, Albert Oriol, MD, MartĂ­nez Joaquin, Montserrat Perez, MD, Rafael Martinez, MD, Raquel de Paz, MD, Miguel Granell, MD, Felipe De Arriba, M. JesĂșs Blanchard, MD, Francisco Javier Peñalver, Jose Luis Bello, MD, Maria Luisa Martin, MD, Joan Bargay, MD, Joan Blade, MD, Juan Jose Lahuerta, MD, JesĂșs F. San Miguel, MD, PhD, Javier De La Rubia, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1973.
https://doi.org/10.1182/blood.V122.21.1973.1973
Published: 2013
Journal Articles

Assessment of Minimal Residual Disease Levels in B-CLL After Front-Line Treatment with FC-R and Rituximab Maintenance

Free
Jose A. Garcia-Vela, MD, Javier Lopez, Secundino Ferrer, Pilar Giraldo, Eva González-Barca, Eulogio Conde, Marcos González, Jose-Luis Guzman, Javier De la Serna, MD, PhD, Mar Osma, MD, Guillermo Deben, MD, Encarna Monzo, MD, Raquel De Paz, MD, Francisco-Javier Penalver, Isidro Jarque, MD, Rafael Martinez, MD, Carmen Burgaleta, Jaime Perez de Oteiza, MD, M.Angeles Andreu, MD, Felix Carbonell, MD, Jose A Garcia-Marco
Journal: Blood
Blood (2012) 120 (21): 4599.
https://doi.org/10.1182/blood.V120.21.4599.4599
Published: 2012
Journal Articles

Final Results of a Multicenter Phase II Trial with Bendamustine and Rituximab As First Line Treatment for Patients with MALT Lymphoma (MALT-2008–01)

Free
Antonio Salar, MD, Eva Domingo-Domenech, MD, Carlos Panizo, Concepción Nicolás, MD, Joan Bargay, Ana Muntanola, MD, Miguel Canales, Jose Luis Bello, MD, juan Manuel Sancho, Sr., MD, Jose Francisco Tomas, MD, María José Rodriguez, MD, Francisco-Javier Penalver, Luis Palomera, MD, Carlos Grande, José J Sánchez-Blanco, MD, Reyes Arranz, MD, Eulogio Conde, Dolores Caballero, MD, Carlos Montalban
Journal: Blood
Blood (2012) 120 (21): 3691.
https://doi.org/10.1182/blood.V120.21.3691.3691
Published: 2012
Journal Articles

Maintenance therapy with bortezomib plus thalidomide or bortezomib plus prednisone in elderly multiple myeloma patients included in the GEM2005MAS65 trial

Free
Clinical Trials & Observations
MarĂ­a-Victoria Mateos, Albert Oriol, JoaquĂ­n MartĂ­nez-LĂłpez, Norma GutiĂ©rrez, Ana-Isabel Teruel, Ana LĂłpez de la GuĂ­a, Javier LĂłpez, Enrique Bengoechea, Montserrat PĂ©rez, Marta Polo, Luis Palomera, Felipe de Arriba, Yolanda GonzĂĄlez, Jose-Mariano HernĂĄndez, Miquel Granell, JosĂ©-Luis Bello, Joan Bargay, Francisco-Javier Peñalver, JosĂ©-MarĂ­a Ribera, MarĂ­a-Luisa MartĂ­n-Mateos, RamĂłn GarcĂ­a-Sanz, Juan-JosĂ© Lahuerta, Joan BladĂ©, JesĂșs F. San-Miguel
Journal: Blood
Blood (2012) 120 (13): 2581–2588.
https://doi.org/10.1182/blood-2012-05-427815
Published: 2012
Includes: Supplemental data
Journal Articles

Outcome according to cytogenetic abnormalities and DNA ploidy in myeloma patients receiving short induction with weekly bortezomib followed by maintenance

Free
Clinical Trials & Observations
MarĂ­a-Victoria Mateos, Norma C. GutiĂ©rrez, MarĂ­a-Luisa MartĂ­n-Ramos, Bruno Paiva, MarĂ­a-Angeles MontalbĂĄn, Albert Oriol, JoaquĂ­n MartĂ­nez-LĂłpez, Ana-Isabel Teruel, Enrique Bengoechea, Alejandro MartĂ­n, JoaquĂ­n DĂ­az-Mediavilla, Felipe de Arriba, Luis Palomera, JosĂ©-Mariano HernĂĄndez, Anna Sureda, Joan Bargay, Francisco-Javier Peñalver, Josep-Maria Ribera, MarĂ­a-Luisa MartĂ­n-Mateos, Manuela FernĂĄndez, RamĂłn GarcĂ­a-Sanz, MarĂ­a-BelĂ©n Vidriales, Joan BladĂ©, Juan-JosĂ© Lahuerta, JesĂșs F. San Miguel
Journal: Blood
Blood (2011) 118 (17): 4547–4553.
https://doi.org/10.1182/blood-2011-04-345801
Published: 2011
Journal Articles

Clinical Outcome According to Both Cytogenetic Abnormalities (CA) Detected by Fluorescence In Situ Hibridization (FISH) and Hyperdiploidy Assessed by Flow Cytometry (FCM) In Elderly Newly Diagnosed Myeloma Patients Treated with A Bortezomib-Based Combination

Free
María-Victoria Mateos, Norma C. Gutierrez, Bruno Paiva, Albert Oriol, Joaquín Martínez-López, Ana Isabel Teruel, Raquel de Paz, Jose Garcia-Laraña, Enrique Bengoechea, Alejandro Martín, Joaquín Díaz-Mediavilla, Luis Palomera, Yolanda Gonzalez, Jose Mariano Hernández, Ana Sureda, Jose Luis Bello, Joan Bargay, Francisco-Javier Penalver, Josep-Maria Ribera, MD, PhD, María-Luisa Martín-Mateos, Ramón García-Sanz, María Teresa Cibeira, MD, PhD, María-Luisa Martín-Ramos, María-Belén Vidriales, María-Angeles Montalbán, Juan-Jose Lahuerta, Joan Blade, Jesús F. San Miguel, Sr, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 309.
https://doi.org/10.1182/blood.V116.21.309.309
Published: 2010
Journal Articles

Rituximab Maintenance Treatment After Combined Fludarabine, Cyclophosphamide and Rituximab In Previously Untreated Patients with Progressive B-Cell Chronic Lymphocytic Leukemia (CLL): Interim Analysis of An Ongoing Phase II Multicenter Trial On Behalf of the Spanish CLL Study Group (GELLC)

Free
Jose A Garcia-Marco, MD, PhD, Javier Lopez-Jimenez, MD, Secundino Ferrer, MD, Pilar Giraldo, MD, PhD, Eva González-Barca, MD, Belen Navarro, MD, Eulogio Conde, MD, PhD, Marcos González, Jose L. Guzman, MD, Ernesto Perez, MD, Javier De la Serna, MD, PhD, Mar Osma, MD, Guillermo Deben, MD, Encarna Monzo, MD, Raquel de Paz, MD, M. Angeles Ruiz, MD, Francisco-Javier Penalver, Isidro Jarque, MD, Helena Bañas, MD, M. Carmen Fernandez, MD, Rafael Martinez, MD, Carmen Burgaleta, MD, Jaime Perez de Oteiza, MD, M.Angeles Andreu, MD, Ana Carral, MD, Inmaculada Fuentes, MD, Eva Donato, MD, Paola Leon, MD, Felix Carbonell, MD, Jose A. Garcia-Vela, MD
Journal: Blood
Blood (2010) 116 (21): 2448.
https://doi.org/10.1182/blood.V116.21.2448.2448
Published: 2010